Cargando…
Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma
Kaposi's sarcoma (KS) is an angioproliferative malignancy whose associated etiologic agent is the Kaposi's sarcoma-associated herpesvirus (KSHV). KS is the most prevalent malignancy among HIV-infected individuals globally and is considered an AIDS-defining malignancy. The different forms o...
Autores principales: | Ngalamika, Owen, Munsaka, Sody |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700054/ https://www.ncbi.nlm.nih.gov/pubmed/33294468 http://dx.doi.org/10.1155/2020/8852221 |
Ejemplares similares
-
Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome
por: Ngalamika, Owen, et al.
Publicado: (2021) -
Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma
por: Ngalamika, Owen, et al.
Publicado: (2020) -
Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
por: Lidenge, Salum J., et al.
Publicado: (2020) -
Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence
por: Ngalamika, Owen, et al.
Publicado: (2021) -
Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study
por: Lungu, Patrick, et al.
Publicado: (2022)